This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cline Scientific Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Cline Scientific's earnings have been declining at an average annual rate of -4.2%, while the Life Sciences industry saw earnings growing at 26.7% annually. Revenues have been growing at an average rate of 12.8% per year.
Belangrijke informatie
-4.2%
Groei van de winst
19.5%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 31.8% |
| Inkomstengroei | 12.8% |
| Rendement op eigen vermogen | -15.7% |
| Nettomarge | -75.0% |
| Laatste winstupdate | 31 Dec 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Cline Scientific geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -3 | 7 | 0 |
| 30 Sep 23 | 4 | -3 | 7 | 0 |
| 30 Jun 23 | 3 | -3 | 6 | 0 |
| 31 Mar 23 | 3 | -3 | 6 | 0 |
| 31 Dec 22 | 3 | -2 | 5 | 0 |
| 30 Sep 22 | 3 | -3 | 5 | 0 |
| 30 Jun 22 | 3 | -3 | 5 | 0 |
| 31 Mar 22 | 3 | -3 | 6 | 0 |
| 31 Dec 21 | 3 | -4 | 6 | 0 |
| 30 Sep 21 | 4 | -2 | 6 | 0 |
| 30 Jun 21 | 3 | -3 | 6 | 0 |
| 31 Mar 21 | 3 | -2 | 5 | 0 |
| 31 Dec 20 | 3 | -2 | 4 | 0 |
| 30 Sep 20 | 3 | -3 | 5 | 0 |
| 30 Jun 20 | 3 | -2 | 5 | 0 |
| 31 Mar 20 | 3 | -2 | 5 | 0 |
| 31 Dec 19 | 3 | -2 | 4 | 0 |
| 30 Sep 19 | 1 | -3 | 4 | 0 |
| 30 Jun 19 | 2 | -3 | 4 | 0 |
| 31 Mar 19 | 2 | -2 | 4 | 0 |
| 31 Dec 18 | 2 | -3 | 4 | 0 |
| 30 Sep 18 | 1 | -3 | 4 | 0 |
| 30 Jun 18 | 0 | -4 | 4 | 0 |
| 31 Mar 18 | 0 | -3 | 4 | 0 |
| 31 Dec 17 | 0 | -3 | 4 | 0 |
| 30 Sep 17 | 1 | -3 | 3 | 0 |
| 30 Jun 17 | 1 | -2 | 3 | 0 |
| 31 Mar 17 | 1 | -2 | 3 | 0 |
| 31 Dec 16 | 1 | -3 | 4 | 0 |
| 30 Sep 16 | 1 | -3 | 4 | 0 |
| 30 Jun 16 | 0 | -3 | 4 | 0 |
| 31 Mar 16 | 0 | -3 | 3 | 0 |
| 31 Dec 15 | 0 | -2 | 3 | 0 |
| 30 Jun 15 | 0 | -3 | 3 | 0 |
| 31 Mar 15 | 0 | -2 | 2 | 0 |
| 31 Dec 14 | 0 | -2 | 2 | 0 |
| 28 Feb 14 | 0 | 0 | 1 | 0 |
Kwaliteitswinsten: CLINE B is currently unprofitable.
Groeiende winstmarge: CLINE B is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CLINE B is unprofitable, and losses have increased over the past 5 years at a rate of 4.2% per year.
Versnelling van de groei: Unable to compare CLINE B's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: CLINE B is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-13%).
Rendement op eigen vermogen
Hoge ROE: CLINE B has a negative Return on Equity (-15.66%), as it is currently unprofitable.